Basic and clinical research in polyomavirus nephropathy.

Medicine and Dentistry

• Nephropathy 100%
• Polyomavirus 100%
• Clinical Research 100%
• Immunosuppressive Treatment 17%
• Kidney Graft 11%
• Prevalence 11%
• Graft Failure 11%
• BK Virus 11%
• In Vitro 5%
• Allograft 5%
• Immunoglobulin 5%
• Antivirus Agent 5%
• Kidney Transplantation 5%
• Virus Replication 5%
• Biopsy Technique 5%
• Retransplantation 5%
• Antiviral Therapy 5%
• Kidney Allograft 5%
• Renal Graft Dysfunction 5%
• Murine Polyomavirus 5%
• Human Polyomavirus 5%
• Nephrotoxicity 5%
• Cidofovir 5%
• Leflunomide 5%

Keyphrases

• Clinical Research 100%
• BK Virus Nephropathy 100%
• BK Polyomavirus (BKPyV) 17%
• Risk Factors 11%
• Immunosuppression 11%
• Graft Loss 11%
• Renal Transplant Recipients 11%
• Complex Interactions 5%
• Screening Method 5%
• Well-defined 5%
• Renal Transplantation 5%
• Graft Outcome 5%
• In Vitro Activity 5%
• Recent Advances 5%
• Virus Replication 5%
• Antiviral Drugs 5%
• Monitoring Method 5%
• Nephrotoxicity 5%
• Definitive Diagnosis 5%
• Etiological Agents 5%
• Serum Markers 5%
• Diagnostic Methods 5%
• Antiviral Treatment 5%
• Screening Diagnosis 5%
• Cidofovir 5%
• Renal Allograft Biopsy 5%
• Immunosuppression Reduction 5%
• Retransplantation 5%
• Intravenous Immunoglobulin (IVIg) 5%
• Leflunomide 5%
• Rejection Episodes 5%
• Urinary Markers 5%
• Histological Assessment 5%
• Renal Allograft Function 5%
• Risk of Rejection 5%
• Donor Factors 5%
• Immune Globulin Therapy 5%
• Recipient Factors 5%
• Mouse Polyomavirus 5%